Literature DB >> 6470814

Meta-[I-131]iodobenzylguanidine uptake in a nonsecreting paraganglioma.

A J Smit, L H van Essen, H Hollema, F A Muskiet, D A Piers.   

Abstract

In a patient with a paraganglioma at the carotid bifurcation, intense uptake of meta-[I-131]iodobenzylguanidine (I-131 MIBG) in the tumor was found. There was no clinical or biochemical evidence for catecholamine secretion by the tumor, although analysis of the tissue revealed that catecholamine biosynthesis took place. We conclude that accumulation of I-131 MIBG may occur in a paraganglioma, but does not necessarily indicate endocrine activity of the tumor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470814

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection?

Authors:  A Osei-Bonsu; E M Kokoschka; W Ulrich; H Sinzinger
Journal:  Eur J Nucl Med       Date:  1989

2.  Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.

Authors:  Y Nakabeppu; M Nakajo
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

3.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

4.  The use of 131I-MIBG in the imaging of metastatic carcinoid tumours.

Authors:  D I Jodrell; A T Irvine; V R McCready; E Woodcraft; I E Smith
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.